Does body mass index, smoking, lipoprotein levels, surgically induced menopause, hormone replacement therapy, years since menopause, or age affect hemostasis in postmenopausal women?

2005 ◽  
Vol 2 (2) ◽  
pp. 88-95 ◽  
Author(s):  
Ulla Pripp ◽  
Margita Eriksson-Berg ◽  
Kristina Orth-Gomér ◽  
Karin Schenck-Gustafsson ◽  
Britt-Marie Landgren
Keyword(s):  
Body Mass Index ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Postmenopausal Women ◽  
Body Mass ◽  
Hormone Replacement ◽  
Surgically Induced

Maximal and submaximal aerobic fitness in postmenopausal women: influence of hormone-replacement therapy

2008 ◽  
Vol 33 (5) ◽  
pp. 922-928 ◽  
Author(s):  
Liza Stathokostas ◽  
John M. Kowalchuk ◽  
Robert J. Petrella ◽  
Donald H. Paterson
Keyword(s):  
Oxygen Consumption ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Postmenopausal Women ◽  
Body Mass ◽  
Aerobic Fitness ◽  
Ventilatory Threshold ◽  
Hormone Replacement ◽  
Peak Oxygen Consumption ◽  
Fitness Parameters

The purpose of this study was to examine whether maximal and submaximal aerobic fitness parameters (peak oxygen consumption and ventilatory threshold, respectively) are affected by hormone-replacement therapy (HRT) in moderately active postmenopausal women. Forty healthy, active, postmenopausal women (21 taking HRT, mean age 62 ± 5 years; 19 not taking HRT, mean age 62 ± 7 years) met the peak oxygen consumption criteria during a cycle ergometer test (15 W ramp) and achieved volitional fatigue. Breath-by-breath measurement was used to determine peak oxygen consumption and to estimate ventilatory threshold. There were no differences in characteristics (age, body mass, height, body mass index, leisure-time physical activity) between the non-HRT and HRT groups, nor were there any differences in responses to maximal exercise, with an observed peak oxygen consumption (mL·kg–1·min–1) of 22.9 ± 3.8 in the non-HRT group and 22.0 ± 4.7 in the HRT group. There was also no difference in submaximal aerobic capacity, with ventilatory threshold values (mL·kg–1·min–1) of 16.7 ± 3.4 in the non-HRT group and 15.6 ± 3.2 in the HRT group. In a sample of healthy moderately active postmenopausal women, there was no difference in maximal or submaximal aerobic fitness parameters beteen the HRT and non-HRT groups.

Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women

Maturitas ◽  
2005 ◽  
Vol 50 (1) ◽  
pp. 19-29 ◽  
Author(s):  
Toshiyuki Yasui ◽  
Hirokazu Uemura ◽  
Yuka Umino ◽  
Masaya Takikawa ◽  
Seiichiro Saito ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Body Mass ◽  
Hormone Replacement ◽  
Estrogen Level

scholarly journals Mammographic density in asymptomatic menopausal women: correlation with clinical and sonographic findings

2012 ◽  
Vol 45 (3) ◽  
pp. 149-154 ◽  
Author(s):  
Beatriz Regina Alvares ◽  
Christian Henrique de Andrade Freitas ◽  
Rodrigo Menezes Jales ◽  
Orlando José de Almeida ◽  
Emílio Francisco Marussi
Keyword(s):  
Body Mass Index ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Body Mass ◽  
Mammographic Density ◽  
Breast Density ◽  
Hormone Replacement ◽  
Mammographic Breast Density ◽  
Asymptomatic Patients ◽  
Menopausal Women

OBJECTIVE: To evaluate mammographic breast density in asymptomatic menopausal women in correlation with clinical and sonographic findings. MATERIALS AND METHODS: Mammograms and clinical and sonographic findings of 238 asymptomatic patients were retrospectively reviewed in the period from February/2022 to June/2006. The following variables were analyzed: mammographic density patterns, sonographic findings, patients' age, parity, body mass index and use of hormone replacement therapy. RESULTS: Age, parity and body mass index showed a negative correlation with breast density pattern, while use of hormone replacement therapy showed a positive correlation. Supplementary breast ultrasonography was performed in 103 (43.2%) patients. Alterations which could not be visualized at mammography were found in 34 (33%) of them, most frequently in women with breast density patterns 3 and 4. CONCLUSION: The authors concluded that breast density patterns were influenced by age, parity, body mass index and time of hormone replacement therapy. Despite not having found any malignant abnormality in the studied cases, the authors have observed a predominance of benign sonographic abnormalities in women with high breast density patterns and without mammographic abnormalities, proving the relevance of supplementary ultrasonography to identify breast lesions in such patients.

Sign in / Sign up

Export Citation Format

Share Document